期刊文献+

间质性肺疾病相关肺动脉高压患者肺动脉收缩压与肺功能指标的相关性研究 被引量:3

Correlation between Pulmonary Artery Systolic Pressure and Pulmonary Function Indexes in Patients with Interstitial Lung Disease Associated Pulmonary Hypertension
下载PDF
导出
摘要 背景肺动脉高压(PH)是一种以肺动脉压升高为主要表现的病理生理状态,可由间质性肺疾病(ILD)引起。目前国内对间质性肺疾病相关肺动脉高压(ILD-PH)患者PH与肺功能相关性的研究很少。目的分析ILDPH患者肺动脉收缩压(PASP)与肺功能指标的相关性。方法回顾性选取2017年7月—2020年7月在南京医科大学附属无锡人民医院就诊的ILD患者202例为研究对象。根据患者是否发生PH,将其分为ILD-PH组(71例)和非ILD-PH组(131例)。收集并比较两组患者一般资料、PASP、肺功能指标,分析ILD-PH患者PASP与肺功能指标的相关性。结果ILD-PH组病程长于非ILD-PH组,尿酸(UA)、D-二聚体(D-D)、丙氨酸氨基转移酶(ALT)、脑钠肽(BNP)、PASP高于非ILD-PH组,血小板计数(PLT)、肺活量百分比(VC%)、第1秒用力呼气容积与用力肺活量比值(FEV_(1)/FVC)低于非ILD-PH组(P<0.05)。ILD-PH患者PASP与最大通气量(MVV)、VC%、用力肺活量占预计值百分比(FVC%)、FEV_(1)/FVC、残气量占肺总量百分比(RV/TLC%)、一氧化碳弥散量(DLCO)呈负相关(P值均<0.05)。结论ILD-PH患者PASP可能与肺功能指标(MVV、VC%、FVC%、FEV_(1)/FVC、RV/TLC%、DLCO)呈负相关。 Background Pulmonary hypertension(PH)is a pathophysiological state characterized by increased pulmonary artery pressure,which can be caused by interstitial lung disease(ILD).At present,there are few studies on the relationship between PH and pulmonary function in patients with interstitial lung disease associated pulmonary hypertension(ILD-PH).Objective To analyze the correlation between pulmonary artery systolic pressure(PASP)and pulmonary function indexes in patients with ILD-PH.Methods A total of 202 patients with ILD who were treated in Wuxi People's Hospital Affiliated to Nanjing Medical University from July 2017 to July 2020 were retrospectively selected as the research objects.According to whether the patients had PH,they were divided into ILD-PH group(71 cases)and non-ILD-PH group(131 cases).The general data,PASP and pulmonary function indexes of the two groups were collected and compared,and the correlation between PASP and pulmonary function indexes in ILD-PH patients was analyzed.Results The disease course of ILD-PH group was longer than that of non-ILD-PH group,uric acid(UA),D-dimer(D-D),alanine aminotransferase(ALT),brain natriuretic peptide(BNP),and PASP were higher than those of non-ILD-PH group,platelet count(PLT),vital capacity percentage(VC%),and the percentage of forced expiratory volume in the first second/forced vital capacity(FEV_(1)/FVC)were lower than those in the non-ILD-PH group(P<0.05).In patients with ILD-PH,PASP was negatively correlated with maximum ventilation(MVV),VC%,forced vital capacity as a percentage of predicted value(FVC%),FEV_(1)/FVC,residual volume as a percentage of total lung volume(RV/TLC%),carbon monoxide diffusion(DLCO)(P values were all<0.05).Conclusion PASP in ILD-PH patients may be negatively correlated with pulmonary function indexes(MVV,VC%,FVC%,FEV_(1)/FVC,RV/TLC%,and DLCO).
作者 孙佳 赵薇 周晓燕 SUN Jia;ZHAO Wei;ZHOU Xiaoyan(Department of Respiratory and Critical Care,Wuxi People's Hospital Affiliated to Nanjing Medical University,Wuxi 214023,China;Department of Respiratory and Critical Care,Wuxi No.5 People's Hospital,Wuxi 214000,China)
出处 《实用心脑肺血管病杂志》 2021年第5期55-58,共4页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
基金 无锡市人民医院科研项目(PKC201705)。
关键词 肺疾病 间质性 高血压 肺性 血压 肺功能 Lung diseases,interstitial Hypertension,pulmonary Blood pressure Pulmonary function
  • 相关文献

参考文献7

二级参考文献58

  • 1马秀云,李培梅,赵军.干燥综合征的肺部表现[J].国外医学(内科学分册),2004,31(10):448-449. 被引量:8
  • 2中华医学会风湿病分会.干燥综合征诊治指南.中华风湿病杂志,2002,.
  • 3American Thoracic Society, Em~opean Respiratory Society. Idiopthic puhnonary fibrosis : diagnosis and statement[ J]. Am J Respir Crit 646. treatmenl. Intemational consensus Care Med,2000,161 (2 Pt 1):.
  • 4FIRESTEINGS.粟占国,唐福林,译.凯利风湿病学[M].北京:北京大学医学出版社,2010:1217.
  • 5吴红梅.原发性干燥综合征合并肺间质病变临床特征分析[J].中外健康文摘,2013,2(10):75.
  • 6RAGHU G,MAGETO YN, LOCKHART D,et al. The accuracy of the chinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: a prospective study [ J ]. Chest, 1999,116(5) :1168.
  • 7TASHKIN DP,ELASHOFF R, CLEMENTS PJ ,eta/. Cyclophosphamide versus placebo in scleroderma lung disease[J]. N Engl J Med,2006,354 (9.5) :2655.
  • 8YAMASKI Y, YAMADA H, YAMASKI M, et al. Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis [ J ]. Rheumetology (Oxford) ,2007,46( 1 ) : 124.
  • 9WINDER A, MOLAD Y, OSTFELD I,et al. Treatment of systemiclupus erythematosus by prolonged administration of high dose intravenous immunoglobulin : report of 2 cases [ J ]. J Rheumaol, 1993,20(3) :495.
  • 10E1SER AR, SHAN1ES HM. Treatment of lupus interstitial lung disease with intraveous cyclophosphamide [ J ]. Arthitis Rheum, 1994,37(3) :428.

共引文献33

同被引文献26

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部